What This Document Is
This is a detailed class outline for PHAR 6124: Pharmacotherapy IV, offered at the University of Minnesota College of Pharmacy. It provides a comprehensive overview of the course structure, schedule, and key areas of focus within advanced pharmacotherapy. The course centers on a patient-centered, pathophysiologic approach to understanding and managing complex disease states. It specifically details the organization of three major therapeutic areas: infectious diseases, oncology, and toxicology.
Why This Document Matters
This outline is essential for students enrolled in, or considering enrollment in, PHAR 6124. It allows prospective students to understand the scope of the course and determine if it aligns with their learning objectives. Current students will find it invaluable for planning their study schedule, understanding course expectations, and identifying important dates like quizzes and exams. Pharmacy professionals seeking a refresher on these core therapeutic areas may also find the overview helpful, though it is tailored to the specific curriculum of this course.
Common Limitations or Challenges
This document is a high-level overview and does *not* contain the detailed lecture notes, case studies, or specific treatment protocols covered in the course. It will not provide you with the in-depth pharmacological mechanisms, clinical guidelines, or patient counseling points discussed in class. Access to the full course materials is required to gain a complete understanding of the topics presented. It also represents the course structure as it was planned for Spring 2009, and may be subject to change in future iterations.
What This Document Provides
* A clear listing of section directors and their contact information for Infectious Diseases, Oncology, and Toxicology.
* The course meeting schedule, including days, times, and location.
* A week-by-week schedule for the Infectious Diseases portion of the course, outlining general topic areas.
* An overview of topics covered in the Toxicology section, including historical perspectives and specific toxic exposures.
* A preliminary schedule for the Oncology component, indicating key cancer types and assessment points.
* Information regarding planned quizzes and a final exam.
